The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study

BACKGROUND: The comprehensive measurement of autoimmune disease-related antibodies (Abs) before immune checkpoint inhibitor (ICI) treatment may be useful for predicting the development of immune-related adverse events (irAEs); however, the clinical utility is not well known. MATERIALS AND METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Izawa, N., Shiokawa, H., Onuki, R., Hamaji, K., Morikawa, K., Saji, H., Ohashi, H., Kasugai, S., Hayakawa, N., Ohara, T., Sunakawa, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058890/
https://www.ncbi.nlm.nih.gov/pubmed/35247869
http://dx.doi.org/10.1016/j.esmoop.2022.100415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058890/
https://www.ncbi.nlm.nih.gov/pubmed/35247869
http://dx.doi.org/10.1016/j.esmoop.2022.100415

Ejemplares similares